Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.571
-0.123 (-17.77%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.560 $0.80 Thursday, 9th May 2024 DBVT stock ended at $0.571. This is 17.77% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 30.36% from a day low at $0.560 to a day high of $0.730.
90 days $0.560 $0.94
52 weeks $0.560 $2.37

Historical DBV Technologies S.A. prices

Date Open High Low Close Volume
Jan 03, 2017 $35.11 $35.31 $34.42 $34.73 47 614
Dec 30, 2016 $34.79 $35.21 $34.66 $35.13 114 622
Dec 29, 2016 $34.59 $34.73 $34.35 $34.40 44 382
Dec 28, 2016 $34.71 $34.71 $34.20 $34.20 15 720
Dec 27, 2016 $35.06 $35.10 $34.69 $34.69 37 647
Dec 23, 2016 $34.89 $35.24 $34.81 $35.08 41 167
Dec 22, 2016 $35.13 $35.54 $34.68 $34.73 55 894
Dec 21, 2016 $35.39 $35.40 $35.00 $35.00 28 177
Dec 20, 2016 $35.24 $35.65 $35.24 $35.50 21 533
Dec 19, 2016 $36.30 $36.30 $35.22 $35.38 75 732
Dec 16, 2016 $36.16 $36.46 $35.81 $36.16 61 340
Dec 15, 2016 $36.33 $36.41 $35.96 $36.37 30 488
Dec 14, 2016 $36.41 $36.72 $36.20 $36.26 33 131
Dec 13, 2016 $36.93 $36.96 $36.66 $36.80 40 936
Dec 12, 2016 $36.75 $37.19 $36.72 $36.90 52 870
Dec 09, 2016 $36.67 $36.95 $36.48 $36.54 36 148
Dec 08, 2016 $36.18 $36.74 $35.59 $36.71 22 062
Dec 07, 2016 $36.52 $36.70 $36.06 $36.18 41 720
Dec 06, 2016 $36.72 $36.79 $36.14 $36.47 43 727
Dec 05, 2016 $36.32 $36.88 $36.20 $36.38 26 201
Dec 02, 2016 $35.85 $36.10 $35.56 $35.65 48 642
Dec 01, 2016 $35.63 $36.35 $35.51 $35.85 135 384
Nov 30, 2016 $36.34 $36.74 $36.28 $36.52 119 882
Nov 29, 2016 $35.86 $36.72 $35.86 $36.61 71 181
Nov 28, 2016 $36.04 $36.21 $35.90 $36.03 50 078
Click to get the best stock tips daily for free!

About DBV Technologies S.A.

DBV Technologies S.A. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVT Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT